GC
BMY icon

Gould Capital’s Bristol-Myers Squibb BMY Stock Holding History

Gould Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.72K Hold
160
– – 0.01% 136
2025
Q4 		$8.64K Hold
160
– – 0.01% 145
2025
Q3 		$7.23K Buy
160
+60
+60% +$2.8K ﹤0.01% 153
2025
Q2 		$4.64K Hold
100
– – ﹤0.01% 164
2025
Q1 		$6.12K Hold
100
– – ﹤0.01% 153
2024
Q4 		$5.67K Sell
100
-1
-1% -$56 ﹤0.01% 156
2024
Q3 		$5.24K Buy
101
+1
+1% +$47 ﹤0.01% 162
2024
Q2 		$4.15K Hold
100
– – ﹤0.01% 170
2024
Q1 		$5.42K Buy
+100
New +$5.09K ﹤0.01% 162

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gould Capital's BMY Position: Q1 2026 in Review

Gould Capital held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 160 shares worth $9.72K. The position accounts for 0.01% of the portfolio, ranked #136.

Gould Capital first reported a position in BMY in Q1 2024 and has held it in 9 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Gould Capital held 160 shares of Bristol-Myers Squibb worth $9.72K as of Q1 2026.
  • Gould Capital left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.01% of Gould Capital's portfolio in Q1 2026, its #136 holding.
  • Gould Capital first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 9 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Gould Capital's 13F filing for Q1 2026, filed 18 May 2026.